Sophie Château‐Joubert

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Florence Coussy, Rania El Botty, Sophie Château‐Joubert et al. · Science Translational Medicine · 2020 · 148 citations · Full text

Medicine, Cancer Biology, Oncology +13

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance

Élodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd et al. · Nature Communications · 2020 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts

Paul Cottu, Elisabetta Marangoni, Franck Assayag et al. · Breast Cancer Research and Treatment · 2011 · 96 citations

Medicine, Endocrinology, Oncology +9

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

Marie‐Emmanuelle Legrier, Ivan Bièche, Julie Gaston et al. · British Journal of Cancer · 2015 · 91 citations · Full text

Medicine, Cancer Biology, Oncology +17

YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer

Hazel M. Quinn, Regina Vogel, Oliver Popp et al. · Cancer Research · 2021 · 85 citations · Full text

Medicine, Cancer Biology, Oncology +17